TrialThe Lancet. Oncology2020

Weekly platinum-based chemotherapy versus 3-weekly platinum-based chemotherapy for newly diagnosed ovarian cancer (ICON8): quality-of-life results of a phase 3, randomised, controlled trial.

Sarah P Blagden et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.